Acer Therapeutics

Cash-strapped Acer sees menopause drug flunk phase 2 trial
Cash-strapped Acer sees menopause drug flunk phase 2 trial
Fierce Biotech
Acer Therapeutics
clinical trials
hot flashes
menopause
osanetant
Flag link:
FDA approves Acer’s olpruva to treat urea cycle disorders
FDA approves Acer’s olpruva to treat urea cycle disorders
Pharmaceutical Business Review
FDA
Acer Therapeutics
olpruva
urea cycle disorders
Flag link:
Rare disease outfit Acer fumbles at FDA, receiving CRL due to lack of inspection readiness at packaging manufacturer
Rare disease outfit Acer fumbles at FDA, receiving CRL due to lack of inspection readiness at packaging manufacturer
Endpoints
Acer Therapeutics
ACER-001
urea cycle disorders
FDA
complete response letter
Flag link:
FDA rejects Acer's rare disease drug, asks for new trial — shares crate
FDA rejects Acer's rare disease drug, asks for new trial — shares crate
Endpoints
Acer Therapeutics
celiprolol
hypertension
clinical trials
FDA
Ehlers-Danlos syndrome
Edsivo
Flag link:
FDA Action Alert: Regeneron, Sanofi, Celgene
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
FDA
drug approvals
Acer Therapeutics
Edsivo
Regeneron
Sanofi
Dupixent
Celgene
Revlimid
Alexion
Soliris
Dova Pharmaceuticals
Doptelet
Nabriva Therapeutics
Contepo
Retrophin
Thiola
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Flag link:
Mark Your Calendar For These June PDUFA Dates
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Flag link:
FDA sets summer PDUFA dates for Acer, Kala therapies
FDA sets summer PDUFA dates for Acer, Kala therapies
BioCentury
FDA
Acer Therapeutics
Kala Pharmaceuticals
Edsivo celiprolol
KPI-121
Flag link: